Cargando…
Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination
Thrombotic thrombocytopenic purpura (TTP) is caused by the deficiency of ADAMTS13, a von Willebrand factor cleaving protease, which results in thrombotic microangiopathy. It is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis leading to organ damage....
Autores principales: | Ramanan, Sruthi, Singh, Harjinder, Menon, Priya, Patel, Parth M, Parmar, Vrajesh, Malik, Devin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521621/ https://www.ncbi.nlm.nih.gov/pubmed/36185943 http://dx.doi.org/10.7759/cureus.28592 |
Ejemplares similares
-
Presentation of Sjogren Syndrome as Nodular Pulmonary Amyloidosis
por: Singh, Harjinder, et al.
Publicado: (2022) -
Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020) -
Dengue Infection Triggering Concurrent Thrombotic Thrombocytopenic Purpura in a Case of Chronic Idiopathic Thrombocytopenic Purpura
por: Rana, Akash, et al.
Publicado: (2023) -
Refractory Thrombotic Thrombocytopenic Purpura to Therapeutic Plasma Exchange
por: Kiamos, Amy, et al.
Publicado: (2022) -
Role of the PLASMIC Score in the Management of Thrombotic Thrombocytopenic Purpura
por: Vyas, Abhinav, et al.
Publicado: (2023)